Cross Country Healthcare (CCRN) reported $309.94 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 25.1%. EPS of $0.04 for the same period compares ...

Cross Country Healthcare (CCRN) reported $309.94 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 25.1%. EPS of $0.04 for the same period compares to $0 ...

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.29 per share a year ago.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

One company value investors might notice is Cross Country Healthcare (CCRN). CCRN is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. We should also highlight that ...

Cross Country (CCRN) delivered earnings and revenue surprises of -63.64% and 1.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Trevi Therapeutics (TRVI – Research Report) and Cross ...